Wednesday, August 13, 2025 NIH-supported trial finds dalbavancin safe, effective for treating bacteremia Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image captured at NIAID’s Rocky Mountain Laboratories (RML) in Hamilton, Montana. NIAID A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated Staphylococcus aureus bloodstream infections …
Read More »Two-dose therapy for S. aureus bloodstream infections on par with standard treatment
